Specialty / Expertise

Myelodysplasia

Research Interests

Current Research Projects

Research Staff

Training

Dr. Scott received his MD from University of South Alabama, Mobile, AL. He completed his Internal Medicine Residency at the Johns Hopkins Hospital, Baltimore, MD. He was a Post-Doctoral Fellow in Oncology at University of Washington, Seattle, WA.

Selected Publications:

Paulo V Campregher, Ted Gooley, Bart L. Scott, Edus H Warren, Carina Moravec, Brenda M Sandmaier, Paul J Martin, Joachim Deeg, Mary E.D. Flowers. Results of Donor Lymphocyte Infusions for Relapsed Myelodysplastic Syndrome after Hematopoeitic Cell Transplantation. Bone Marrow Transplantation. 2007;40:965-971

Mohamed L. Sorror, Brenda M. Sandmaier Barry E. Storer, Michael B. Maris, Frédéric Baron, David G. Maloney, Bart L. Scott, H. Joachim Deeg, Frederick R. Appelbaum, and Rainer Storb. Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncology 2007;25:4246-4254

Daniella M. B. Kerbauy, Theodore A. Gooley, George E. Sale, Mary E. D. Flowers, Kristine C. Doney, George E. Georges, Joanne E. Greene, Michael Linenberger, Effie Petersdorf, Brenda M. Sandmaier, Bart L. Scott, Mohamed Sorror, Derek L. Stirewalt, F. Marc Stewart, Robert P. Witherspoon, Rainer Storb, Frederick R. Appelbaum, H. Joachim Deeg. Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia. Biol Blood Marrow Transplant. 2007;13:355-365

Chunkang Chang, Barry E. Storer, Bart L. Scott, Eileen M. Bryant, Howard M. Shulman, Mary E. Flowers, Brenda M. Sandmaier, Robert P. Witherspoon, Richard A. Nash, Jean E. Sanders, Antonio Bedalov, John A. Hansen, Bruce E. Clurman, Rainer Storb, Frederick R. Appelbaum, and H. Joachim Deeg. Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia Arising From Myelodysplastic Syndrome: Similar Outcomes in Patients with De Novo Disease and Diseases Following Prior Therapy or Antecedent Hematologic Disorders. Blood 2007;110:1379-1387

Scott B.L., Storer B.E., Greene J.E., Hackman R.C., Appelbaum F. R., Deeg H.J. Marrow Fibrosis as a Risk Factor for Post-transplant Outcome in Patients with Advanced MDS or AML with Multilineage Dysplasia. Biol Blood Marrow Transplant. 2007; 13: 345-354

H. Joachim Deeg, MD; Barry E. Storer; Michael Boeckh; Paul J. Martin; Jeannine S. McCune; David Myerson; Shelly Heimfeld; Mary E. Flowers; Claudio Anasetti; Kristine C. Doney; John A. Hansen; Hans-Peter Kiem; Richard A. Nash; Paul V. O'Donnell; Jerald P. Radich; Brenda M. Sandmaier; Bart L. Scott; E. Houston Warren; Robert P. Witherspoon; Ann Woolfrey; Frederick R. Appelbaum; Rainer Storb. Reduced Incidence of Acute and Chronic GVHD with the Addition of Thymoglobulin to a Targeted Busulfan/Cyclophosphamide Regimen. Biol Blood Marrow Transplant. 2006;12:573-584